Wiener klinisches Magazin

, Volume 15, Issue 6, pp 32–37 | Cite as

Akute respiratorische Insuffizienz

Extrakorporale Membranoxygenierung kann die Prognose verbessern
  • Matthias Hecker
  • Markus Alexander Weigand
  • Konstantin Mayer
pulmologie
  • 75 Downloads

Zusammenfassung

Die akute respiratorische Insuffizienz [„acute respiratory distress syndrome“ (ARDS)] stellt aufgrund ihrer Komplexität und schlechten Prognose eine enorme intensivmedizinische Herausforderung dar. Trotz aller Fortschritte in Forschung und Therapie bleibt die Letalität unakzeptabel hoch. Ziel des vorliegenden Artikels ist es, Definitionen, klinische Charakteristika und die Pathogenese des ARDS kurz zu skizzieren und auf gegenwärtige Therapieoptionen und zukünftige Entwicklungen in der Behandlung des ARDS einzugehen.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Abraham E et al (1999) Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. TLC C-53 ARDS Study Group. Crit Care Med 27:1478–1485PubMedCrossRefGoogle Scholar
  2. 2.
    Abroug F, Ouanes-Besbes L, Dachraoui F et al (2011) An updated study-level meta-analysis of randomised controlled trials on proning in ARDS and acute lung injury. Crit Care 15:R6PubMedCrossRefGoogle Scholar
  3. 3.
    ARDS Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 342:1301–1308CrossRefGoogle Scholar
  4. 4.
    Ashbaugh DG, Bigelow DB, Petty TL et al (1967) Acute respiratory distress in adults. Lancet 2:319–323PubMedCrossRefGoogle Scholar
  5. 5.
    Bernard GR, Artigas A, Brigham KL et al (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824PubMedCrossRefGoogle Scholar
  6. 6.
    Brower RG, Lanken PN, MacIntyre N et al (2004) Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 351:327–336PubMedCrossRefGoogle Scholar
  7. 7.
    Brun-Buisson C, Minelli C, Bertolini G et al (2004) Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study. Intensive Care Med 30:51–61PubMedCrossRefGoogle Scholar
  8. 8.
    Dreyfuss D, Soler P, Basset G et al (1988) High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 137:1159–1164PubMedCrossRefGoogle Scholar
  9. 9.
    Felbinger TW, Weigand MA, Mayer K (2012) Supplementation in acute lung injury. JAMA 307:144 (Erwiderung der Autoren: 145-146)PubMedCrossRefGoogle Scholar
  10. 10.
    Gao Smith F, Perkins GD, Gates S et al (2012) Effect of intravenous beta-2 agonist treatment on clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre, randomised controlled trial. Lancet 379:229–235PubMedCrossRefGoogle Scholar
  11. 11.
    Goss CH, Brower RG, Hudson LD et al (2003) Incidence of acute lung injury in the United States. Crit Care Med 31:1607–1611PubMedCrossRefGoogle Scholar
  12. 12.
    Herridge MS, Cheung AM, Tansey CM et al (2003) One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 348:683–693PubMedCrossRefGoogle Scholar
  13. 13.
    Herridge MS, Tansey CM, Matte A et al (2011) Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med 364:1293–1304PubMedCrossRefGoogle Scholar
  14. 14.
    Hudson LD, Milberg JA, Anardi D et al (1995) Clinical risks for development of the acute respiratory distress syndrome. Am J Respir Crit Care Med 151:293–301PubMedCrossRefGoogle Scholar
  15. 15.
    Michael JR, Barton RG, Saffle JR et al (1998) Inhaled nitric oxide versus conventional therapy: effect on oxygenation in ARDS. Am J Respir Crit Care Med 157:1372–1380PubMedCrossRefGoogle Scholar
  16. 16.
    Papazian L, Forel JM, Gacouin A et al (2010) Neuromuscular blockers in early acute respiratory distress syndrome. N Engl J Med 363:1107–1116PubMedCrossRefGoogle Scholar
  17. 17.
    Peek GJ, Mugford M, Tiruvoipati R et al (2009) Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 374:1351–1363PubMedCrossRefGoogle Scholar
  18. 18.
    Rice TW, Wheeler AP, Thompson BT et al (2011) Enteral omega-3 fatty acid, gamma-linolenic acid, and antioxidant supplementation in acute lung injury. JAMA 306:1574–1581PubMedCrossRefGoogle Scholar
  19. 19.
    Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMedCrossRefGoogle Scholar
  20. 20.
    Steinberg KP, Hudson LD, Goodman RB et al (2006) Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 354:1671–1684PubMedCrossRefGoogle Scholar
  21. 21.
    Walmrath D, Schneider T, Pilch J et al (1993) Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet 342:961–962PubMedCrossRefGoogle Scholar
  22. 22.
    Wheeler AP, Bernard GR (2007) Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet 369:1553–1564PubMedCrossRefGoogle Scholar
  23. 23.
    Wiedemann HP, Wheeler AP, Bernard GR et al (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2012

Authors and Affiliations

  • Matthias Hecker
    • 1
  • Markus Alexander Weigand
    • 2
  • Konstantin Mayer
    • 1
  1. 1.Medizinische Klinik II (Pneumologie/internistische Intensivmedizin)Universitätsklinikum Gießen und Marburg, Standort GießenGießenDeutschland
  2. 2.Klinik für Anaesthesiologie und Operative IntensivmedizinUniversitätsklinikum Gießen und Marburg, Standort GießenGießenDeutschland

Personalised recommendations